Bacil Pharma Ltd — Board Meeting, 29-08-2026: Board Meeting
29-08-2026 | 01:21 pm
29-08-2026 | 01:21 pm
Bacil Pharma's board approved the 39th AGM. Key items include a boost in authorized share capital from ₹20 Cr to ₹70 Cr. Leadership moves include Chaitali Shah's MD re-designation and several director regularizations, plus a new auditor.
No comments yet. Be the first to comment!
